BiotechDispatch - Biotech

Latest News

NeuroScientific Biopharmaceuticals updates on early-stage trial
June 30, 2022
Latest News

New leadership for medtech regulatory advisory group
June 30, 2022
Latest News

Starpharma's anti-viral nasal spray relaunched in the UK
June 30, 2022

Latest News Novotech secures regional 'Best Biologics CRO' award June 30, 2022
Asia Pacific-based Novotech, which recently expanded its services to the US, has been awarded the Best Biologics CRO Award.
Latest News Digital clinical trial recruitment platform in new agreements with patient groups June 30, 2022
The agreements with Neuroendocrine Cancer Australia and Pancare Foundation aim to facilitate the rapid recruitment of patients in new trials via Opyl's Opin digital platform.
Latest News Orthocell announces new agreement with US-based BioHorizons June 28, 2022
Regenerative medicine company Orthocell (ASX:OCC) has entered into an exclusive patent and trademark license agreement and an exclusive distribution and supply agreement with BioHorizons Implant Systems.
AusBiotech Investment funds support university commercialisation June 28, 2022
AusBiotech welcomes the announcement of two new university-specific investment funds, totalling $115 million, created in collaboration with Tanarra Capital, the University of Melbourne and Victorian State Government-funded Breakthrough Victoria.
Latest News Starpharma signs expanded DEP research agreement with Genentech June 28, 2022
Starpharma (ASX:SPL) has signed an expanded DEP research agreement with Genentech, a member of the Roche Group, to evaluate additional DEP drug conjugates.
MGC Pharmaceuticals updates on pre-clinical trial progress June 28, 2022
MGC Pharmaceuticals (ASX:MXC) has provided an update on its pre-clinical in vitro study of CimetrA.
Latest News Lumos Diagnostics secures authorisation for test in Canada June 28, 2022
Lumos Diagnostics (ASX:LDX) has announced it has received Interim Order authorisation from Health Canada for its ViraDx three-in-one rapid antigen test for COVID-19, Flu A and Flu B.
Latest News ‘Goldilocks’ treatment window could lead to cancer therapy without harmful side-effects June 23, 2022
A team of Australian-Israeli researchers have developed a way to potentially reduce the toxic side-effects of a type of immunotherapy, in findings that could overcome the pioneering treatment’s biggest limitation.
AusBiotech NSW and QLD Government investments into industry welcomed June 23, 2022
AusBiotech has welcomed the investment into the life sciences industry through this week’s New South Wales and Queensland Budgets, as well as the recognition of biotech’s ability to “underpin the jobs, businesses and industries of the future”.
Latest News Volpara Health in new collaboration with Microsoft June 23, 2022
Volpara Health Technologies (ASX:VHT) has announced a new research and development collaboration with Microsoft to accelerate the creation of a product that detects and quantifies breast arterial calcifications.
Latest News Victorian government grant to Hudson Institute for collaboration with Noxopharm June 23, 2022
The Victorian Government has granted Noxopharm (ASX:NOX) collaborator Hudson Institute of Medical Research a grant of $1.45 million to fund the joint development program of novel anti-inflammatory compounds.
Latest News Trajan announces share purchase plan after successful institutional placement June 23, 2022
Global analytical science and device company Trajan (ASX:TRJ) has launched its Share Purchase Plan (SPP) with the intention of raising up to $5 million.
Latest News Vaccine manufacturing facility secures Queensland government funding June 20, 2022
A medical manufacturing facility equipped to produce therapeutics for clinical trials will be built in Brisbane with up to $60 million in funding from the Queensland Government.
AusBiotech High appetite for biotech VC cited in new report June 21, 2022
A recent report published by US-based firm McKinsey & Company has cited that venture capital (VC) investment in the biotech industry has boomed over the past three years.
Latest News Life sciences industry says IP waiver an 'empty shell' and fact-free decision June 20, 2022
The research-based life sciences industry says the decision to waive intellectual property protections for COVID-19 vaccines is fundamentally flawed and will have a negative impact on future innovation.
Latest News Trajan acquires US-based manufacturer Chromatography Research Supplies June 20, 2022
Global analytical science and device company Trajan Group Holdings (ASX:TRJ) has today announced the signing of a binding share purchase agreement and a real estate purchase agreement to acquire 100 per cent of Chromatography Research Supplies.
Latest News New orphan drug designation for Kazia Therapeutics' paxalisib June 20, 2022
Kazia Therapeutics (ASX:KZA) has announced that the US FDA has granted Orphan Drug Designation to its paxalisib for the treatment of atypical rhabdoid/teratoid tumours.

Most Read

New Stories